V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220008225 | 220003299 | 1.83 | 92.85 | Curative (C) | 2014-05-06 | 2014-05-06 | Cytarabine High Dose | N | N | 220034081 | CYTARABINE HIGH DOSE |
| 220008226 | 220003300 | 1.8 | 86.7 | Palliative (P) | 2018-01-17 | 2018-01-17 | RAVVA TRIAL | 02 | N | 220034084 | PEMBROLIZUMAB |
| 220008227 | 220003300 | 1.54 | 69.4 | Palliative (P) | 2016-04-08 | 2016-04-25 | Rituximab | 2 | N | 220034084 | RITUXIMAB |
| 220008228 | 220003300 | 1.61 | 99.2 | Curative (C) | 2014-03-02 | 2014-03-03 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | Y | 220034084 | RITUXIMAB |
| 220008229 | 220003300 | 1.86 | 67.7 | Palliative (P) | 2016-05-02 | 2016-05-22 | Carboplatin + Etoposide IV 3 day | N | N | 220034084 | CARBOPLATIN + ETOPOSIDE |
| 220008230 | 220003300 | 1.78 | null | null | 2017-03-17 | 2017-03-24 | Carboplatin + Etoposide iv&po | null | null | 220034084 | CARBOPLATIN + ETOPOSIDE |
| 220008231 | 220003300 | 1.78 | 76 | Palliative (P) | 2013-07-15 | 2013-07-15 | GEMCITABINE | 1 | N | 220034084 | RAVVA TRIAL |
| 220008232 | 220003300 | 1.7 | null | Curative (C) | 2017-07-21 | 2017-07-22 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220034084 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008233 | 220022026 | 1.8 | 102 | Curative (C) | 2018-07-02 | 2018-10-01 | Cytarabine High Dose | 2 | N | 220034094 | CYTARABINE HIGH DOSE |
| 220008234 | 220003301 | 1.89 | null | Palliative (P) | 2014-03-30 | 2014-04-14 | EOX | 02 | Y | 220034100 | EOX |
| 220008235 | 220003301 | 1.55 | 89 | Palliative (P) | 2015-10-30 | 2015-11-03 | EOX | N | N | 220034100 | EOX |
| 220008236 | 220003301 | 1.77 | 63.8 | Curative (C) | 2017-03-05 | 2017-03-10 | FLAG | 02 | Y | 220034100 | FLAG |
| 220008237 | 220003301 | 1.73 | 80.2 | Curative (C) | 2015-07-01 | 2015-07-01 | FLAG | N | N | 220034100 | FLAG |
| 220008238 | 220003301 | 0 | 80 | Palliative (P) | 2014-01-24 | 2014-01-27 | RAVVA TRIAL | 02 | N | 220034100 | RITUXIMAB |
| 220008239 | 220003301 | null | 80 | null | 2015-07-16 | 2015-07-23 | PEMBROLIZUMAB | N | null | 220034100 | RAVVA TRIAL |
| 220008240 | 220003302 | 1.59 | 63 | Palliative (P) | 2016-04-26 | 2016-05-12 | EOX | N | N | 220034109 | EOX |
| 220008241 | 220003303 | 1.8 | 102.4 | Curative (C) | 2016-09-26 | 2016-09-28 | Cytarabine High Dose | N | N | 220034115 | CYTARABINE HIGH DOSE |
| 220008242 | 220003303 | 1.57 | 59 | Palliative (P) | 2014-03-01 | 2014-03-01 | EOX | N | N | 220034115 | EOX |
| 220008243 | 220003303 | null | 67.7 | Curative (C) | 2013-05-07 | 2013-05-12 | AML Int Guide ADE 8+3+5 (2) | 02 | null | 220034115 | ADE |
| 220008244 | 220003303 | null | 100 | Disease modification (D) | 2017-01-25 | 2017-01-30 | PEMBROLIZUMAB | N | null | 220034115 | RITUXIMAB |
| 220008245 | 220003303 | 1.75 | 81 | Palliative (P) | 2014-07-30 | 2014-07-31 | ECX | N | N | 220034115 | ECX |
| 220008246 | 220003304 | null | 53.7 | Palliative (P) | 2013-03-28 | 2013-03-28 | EOX | N | N | 220034124 | EOX |
| 220008247 | 220003305 | 1.81 | 70 | Palliative (P) | 2017-12-01 | 2017-12-01 | RAVVA TRIAL | 02 | N | 220034127 | GEMCITABINE |
| 220008248 | 220003305 | 0 | 60 | Curative (C) | null | 2017-03-03 | Cytarabine High Dose | N | N | 220034127 | CYTARABINE HIGH DOSE |
| 220008249 | 220016364 | null | 31.9 | null | null | 2017-12-14 | CAPECITABINE + OXALIPLATIN | N | N | 220034132 | CAPECITABINE + OXALIPLATIN |
| 220008250 | 220003306 | null | 69 | Palliative (P) | 2016-02-12 | 2016-02-12 | Carboplatin + Etoposide IV 3 day | null | N | 220034133 | CARBOPLATIN + ETOPOSIDE |
| 220008251 | 220003307 | 1.75 | 110 | Palliative (P) | 2013-05-23 | 2013-05-28 | ECX | 2 | null | 220034134 | ECX |
| 220008254 | 220016365 | 1.86 | 80.2 | Adjuvant (A) | 2013-07-18 | 2013-07-22 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220034137 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008255 | 220016365 | 1.8 | 105.6 | Palliative (P) | 2017-05-03 | 2017-05-03 | EOX | 02 | N | 220034137 | EOX |
| 220008256 | 220016365 | 1.65 | 62 | Palliative (P) | 2016-04-04 | 2016-04-04 | CARBOPLATIN + ETOPOSIDE | N | N | 220034137 | CARBOPLATIN + ETOPOSIDE |
| 220008257 | 220016365 | 1.73 | 72.2 | Curative (C) | 2013-08-20 | 2013-08-21 | FLAG | Y | null | 220034137 | FLAG |
| 220008258 | 220016365 | 1.68 | 86 | Not known (9) | 2014-01-04 | 2014-01-04 | Gemcitabine weekly | N | N | 220034137 | RITUXIMAB |
| 220008259 | 220016365 | 1.67 | 71.1 | Palliative (P) | 2014-03-25 | 2014-03-31 | Oxaliplatin + Modified de Gramont | N | N | 220034137 | OXALIPLATIN + MDG |
| 220008260 | 220016365 | 1.78 | 82 | Curative (C) | 2015-08-11 | 2015-11-03 | Cytarabine High Dose | N | N | 220034137 | CYTARABINE HIGH DOSE |
| 220008261 | 220003309 | null | 61.1 | Not known (9) | 2014-04-08 | 2014-04-14 | Carboplatin AUC 2 - 5 | null | null | 220034152 | CARBOPLATIN |
| 220008262 | 220003310 | 1.7 | 110 | Curative (C) | 2014-11-07 | 2014-11-07 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034155 | ADE |
| 220008263 | 220003311 | 1.77 | 74 | Curative (C) | 2015-08-28 | 2015-08-28 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220034156 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220008264 | 220011826 | null | 70.4 | Palliative (P) | 2016-08-27 | 2016-09-10 | PEMBROLIZUMAB | N | N | 220034158 | PEMBROLIZUMAB |
| 220008265 | 220003312 | 1.66 | 69.6 | Adjuvant (A) | 2017-01-07 | 2017-01-09 | Cisplatin + Radiotherapy + CISPLATIN | N | N | 220034159 | CISPLATIN + RT |
| 220008266 | 220003312 | null | 23.1 | Curative (C) | 2013-01-21 | 2013-01-26 | FLAG | N | N | 220034159 | FLAG |
| 220008267 | 220016366 | 1.65 | 82 | Palliative (P) | null | 2017-07-13 | ECX | 02 | N | 220034163 | ECX |
| 220008268 | 220003313 | 1.81 | 69.6 | Curative (C) | 2017-11-08 | 2017-11-09 | AML Int Guide ADE 10+3+5 (1) | N | N | 220034164 | ADE |
| 220008272 | 220018970 | null | 74 | Palliative (P) | 2017-10-29 | 2017-10-30 | Gemcitabine 1000mg/m2 D1 8 15 | Y | N | 220034174 | RITUXIMAB |
| 220008273 | 220018970 | 1.57 | 68 | Palliative (P) | 2017-05-15 | 2017-05-15 | ECX | 02 | N | 220034174 | ECX |
| 220008274 | 220003315 | null | 68.7 | Disease modification (D) | 2014-09-27 | 2014-09-28 | PEMBROLIZUMAB | null | null | 220034180 | GEMCITABINE |
| 220008275 | 220003316 | 1.89 | 66.6 | Palliative (P) | 2017-04-11 | 2017-04-11 | Carboplatin AUC 2 - 5 | N | null | 220034182 | CARBOPLATIN |
| 220008276 | 220003317 | 1.61 | 59.3 | Palliative (P) | 2016-10-22 | 2016-10-26 | EOX | 02 | N | 220034187 | EOX |
| 220008277 | 220003318 | null | 13.4 | null | 2018-04-15 | 2018-04-15 | RAVVA TRIAL | null | null | 220034189 | RITUXIMAB |
| 220008278 | 220003318 | 1.48 | 52 | Curative (C) | 2017-02-01 | 2017-02-01 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 220034189 | CISPLATIN + RT |
| 220008279 | 220003318 | 1.74 | 99 | Palliative (P) | 2018-07-12 | 2018-07-13 | Gemcitabine weekly | 02 | N | 220034189 | GEMCITABINE |